Azobenzenes
Medchemexpress LLC Cadrofloxacin 100mg | 153808-85-6 | 100 MG
Cadrofloxacin is an orally active fluoroquinolone antibiotic research chemical with activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria. It is supplied as a powder for laboratory research and analytical applications.
- High purity: 98.2%.
- Molecular weight: 411.38 g/mol.
- Chemical formula: C19H20F3N3O4.
- CAS number: 153808-85-6.
- Supplied as a powder, stable at -20°C for long-term storage.
- Available in 100 MG quantity for research use.
Medchemexpress LLC C-021 | 864289-85-0 | 100.0% | 467.65 g/mol | C27H41N5O2 | 25 MG
C-021 is a small-molecule CCR4 antagonist supplied for research use. It inhibits CCR4-mediated chemotaxis in human and mouse cells and blocks CCL22-induced GTPγS binding, making it suitable for biochemical and cellular assays.
- Target: CCR4 (GPCR), suitable for immunology and GPCR research.
- Potent CCR4 antagonist with reported IC50s of 140 nM (human chemotaxis), 39 nM (mouse chemotaxis), and 18 nM in GTPγS binding assays.
- Molecular formula C27H41N5O2 and molecular weight 467.65 g/mol.
- Reported purity 99.95% and solid appearance (off-white to light yellow).
- Recommended storage: powder -20°C (up to 3 years) or 4°C (up to 2 years); in solvent -80°C (6 months) or -20°C (1 month).
- Intended for research use only; not for human or animal therapeutic use.
![Medchemexpress LLC Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N' | 1166393-85-6 | 98.6% | 445.52 | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000387730-logo.png-250.jpg){kind=logo}
Medchemexpress LLC Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N' | 1166393-85-6 | 98.6% | 445.52 | 50 MG
PF-4618433 is a potent and selective PYK2 inhibitor, with an IC50 of 637 nM. It may be suitable for the research of osteoporosis, craniofacial and appendicular skeletal defects, and for targeted bone regeneration.
- Potent and selective PYK2 inhibitor with an IC50 of 637 nM.
- Promotes osteogenesis of hMSC cultures, increasing alkaline phosphatase (ALP) activity and mineralization.
- Enhances osteoblast proliferation.
- Enhances calcium deposition.
- Increases cell proliferation activity in murine bone marrow-derived mesenchymal stem cells (BMSC).
![Medchemexpress LLC 4-N,6-N-bis[(4-fluoro-3-methylphenyl)methyl]pyrimidine-4,6-dicarboxamide | 544678-85-5 | MFCD09878513 | 99.2% | 410.42 g/mol | C22H20F2N4O2 | 1MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000238385.png-250.jpg)
Medchemexpress LLC 4-N,6-N-bis[(4-fluoro-3-methylphenyl)methyl]pyrimidine-4,6-dicarboxamide | 544678-85-5 | MFCD09878513 | 99.2% | 410.42 g/mol | C22H20F2N4O2 | 1MG
DB04760 is a potent, highly selective, non-zinc-chelating inhibitor of matrix metalloproteinase-13 (MMP-13) with a reported biochemical IC50 of 8 nM. Preclinical studies show the compound reduces paclitaxel-induced neurotoxicity and exhibits anticancer activity. The material is supplied as a light yellow to yellow solid with high purity and recommended storage conditions for powder and solution forms.
Medchemexpress LLC Atuliflapon (AZD5718) | 2041075-86-7 | 99.0% | 25 MG
Atuliflapon (AZD5718) is a small-molecule, orally active inhibitor of 5-lipoxygenase activating protein (FLAP) used in preclinical and clinical research to modulate leukotriene biosynthesis and investigate cardiovascular inflammation.
- Inhibits FLAP with low-nanomolar potency in clinical studies.
- Demonstrates target engagement via reduced LTB4 and LTE4 biomarkers.
- Suitable for in vitro human and translational studies; species-dependent activity limits some animal models.
- Provided as a solid powder with high purity for research use.
Medchemexpress LLC Atuliflapon (AZD5718) | 2041075-86-7 | 99.0% | 100 MG
Atuliflapon (AZD5718) is a small-molecule, orally active inhibitor of 5-lipoxygenase activating protein (FLAP) investigated as a research compound for cardiovascular indications such as coronary artery disease. It potently suppresses leukotriene production and has documented preclinical and clinical pharmacology data.
- Oral FLAP inhibitor with potent activity (reported FLAP IC50 ≈ 2 nM).
- Reduces leukotriene production in human whole blood.
- Reported molecular weight 446.50 g·mol⁻¹ and formula C24H26N6O3.
- High purity (about 99.0%), white to off-white solid.
- Soluble in DMSO (≈125 mg/mL); sonication may be required for full dissolution.
- Powder storage: -20°C for long-term stability; in solvent, store at -80°C when possible.
![eMolecules ChemScene / 14-Dioxaspiro[4.4]nonane-6-carboxylic acid / 100mg / 761228852 / CS-0613736 / 0.000 / 38853-85-9 / MFCD20639843 / 172.180 / C8H12O4](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502464634.JPG-250.jpg)
eMolecules ChemScene / 14-Dioxaspiro[4.4]nonane-6-carboxylic acid / 100mg / 761228852 / CS-0613736 / 0.000 / 38853-85-9 / MFCD20639843 / 172.180 / C8H12O4
ChemScene / 14-Dioxaspiro[4.4]nonane-6-carboxylic acid / 100mg / 761228852 / CS-0613736 / 0.000 / 38853-85-9 / MFCD20639843 / 172.180 / C8H12O4
eMolecules AstaTech / ISOPROPYL(2-NITROPHENYL)SULFANE / 0.25g / 434269003 / W12996 / 95.000 / 70415-85-9 / MFCD13689000 / 197.250 / C9H11NO2S
AstaTech / ISOPROPYL(2-NITROPHENYL)SULFANE / 0.25g / 434269003 / W12996 / 95.000 / 70415-85-9 / MFCD13689000 / 197.250 / C9H11NO2S
Medchemexpress LLC 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | 274925-86-9 | MFCD09954136 | 99.9% | 273.24 | C14H11NO5 | 50 MG
Nebicapone is a reversible catechol-O-methyltransferase (COMT) inhibitor provided as a solid research compound for in vitro and in vivo studies. It is used to study COMT-mediated metabolism of L-DOPA and related pharmacology, and is supplied with characterization data and storage recommendations for experimental stability.
- Reversible COMT inhibitor for research use.
- Reported purity 99.9%.
- Molecular weight 273.24 g/mol.
- Physical form solid powder.
- High solubility in DMSO (≥100 mg/mL) and formulated in vivo solubility ≥2.5 mg/mL in 10% DMSO/40% PEG300/5% Tween-80/45% saline.
- Recommended storage 4°C protected from light; in solution store at -80°C up to 6 months or -20°C up to 1 month.
![eMolecules Medchem Express / GSK962 / 5mg / 489862907 / HY-103028 / / 2049872-86-6 / [null] / 230.311 / C14H18N2O](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502463926.JPG-250.jpg)
eMolecules Medchem Express / GSK962 / 5mg / 489862907 / HY-103028 / / 2049872-86-6 / [null] / 230.311 / C14H18N2O
Medchem Express / GSK962 / 5mg / 489862907 / HY-103028 / / 2049872-86-6 / [null] / 230.311 / C14H18N2O
eMolecules ChemScene / 36-Dibromopicolinaldehyde / 100mg / 714110566 / CS-0146972 / 0.000 / 1215183-85-9 / MFCD16250664 / 264.904 / C6H3Br2NO
ChemScene / 36-Dibromopicolinaldehyde / 100mg / 714110566 / CS-0146972 / 0.000 / 1215183-85-9 / MFCD16250664 / 264.904 / C6H3Br2NO
Medchemexpress LLC 2-(2,2,3,3,3-pentafluoropropoxy)-3-(4-(2,2,2-trifluoroethoxy)phenyl)-5,7-dihydropyrrolopyrimidine-4,6-dione | 1236767-85-3 | 99.9% | 473.27 | C17H11F8N3O4 | 100 MG
D5D-IN-326 is a selective, orally active delta-5 desaturase (D5D) inhibitor supplied as a powder for research use. It shows low-nanomolar potency (IC50 22 nM human, 72 nM rat), has molecular weight 473.27, and is reported at high purity (99.9%). Preclinical studies indicate improved insulin sensitivity and weight reduction in diet-induced obese mice. Store and handle per the manufacturer's recommendations.
- Selective delta-5 desaturase inhibitor with low-nanomolar potency.
- High purity suitable for pharmacology studies (99.9%).
- Powder form, convenient for formulation and dosing.
- Suitable for in vitro and in vivo pharmacology studies.
- Certificate of analysis and safety data sheet available.
- Defined storage conditions for powder and solutions to preserve stability.